Literature DB >> 29763669

Travel-related health problems in the immunocompromised traveller: An exploratory study.

Mariëlle van Aalst1, Marella C E van Ruissen1, Roos Verhoeven1, Godelieve J de Bree2, Abraham Goorhuis1, Martin P Grobusch3.   

Abstract

BACKGROUND: Immunocompromised travellers (ICTs) are at increased risk of travel-related health problems. Therefore, they are advised to attend specialised pre-travel clinics for advice on vaccination, malaria chemoprophylaxis and on-demand antibiotics. However, studies yield conflicting data regarding travel-related health problems encountered by ICTs; questioning the rationale for certain advices, and particularly the advice of on-demand antibiotics.
OBJECTIVE: To evaluate self-reported travel-related health problems, antibiotic use, medical visits and risk behaviours in ICTs and controls.
METHODS: We conducted a questionnaire-based observational study with pilot character. We recruited participants from a (medical) pre-travel clinic. Telephone interviews were conducted 2-4 weeks post-travelling, applying a structured questionnaire.
RESULTS: We included 30 ICTs and 30 controls. More ICTs than controls reported travel-related health problems, antibiotic use and medical visits, although not statistically significant. Travellers' diarrhoea appeared to be more severe in ICTs. Furthermore one ICT was hospitalized post-travel due to pneumonia. Of ICTs, 2/30 (7%) used on demand antibiotics while not indicated (according to the protocol of the Dutch national coordinating centre for travel advice or prescribed by a physician). Reversely, 6/30 (20%) did not use on demand antibiotics while actually indicated according to this protocol. DISCUSSION: Our findings substantiate the recommendation of on demand antibiotics. However, ICTs did often not use on demand antibiotics correctly; they therefore need very careful instructions.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Immunocompromised traveller; Immunodeficiency; Travel; Travellers' diarrhoea

Mesh:

Substances:

Year:  2018        PMID: 29763669     DOI: 10.1016/j.tmaid.2018.05.005

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  2 in total

1.  Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance data.

Authors:  Martin P Grobusch; Leisa Weld; Abraham Goorhuis; Davidson H Hamer; Mirjam Schunk; Sabine Jordan; Frank P Mockenhaupt; François Chappuis; Hilmir Asgeirsson; Eric Caumes; Mogens Jensenius; Perry J J van Genderen; Francesco Castelli; Rogelio López-Velez; Vanessa Field; Emmanuel Bottieau; Israel Molina; Christophe Rapp; Marta Díaz Ménendez; Effrossyni Gkrania-Klotsas; Carsten S Larsen; Denis Malvy; David Lalloo; Federico Gobbi; Simin A Florescu; Philippe Gautret; Patricia Schlagenhauf
Journal:  Lancet Reg Health Eur       Date:  2020-11-12

2.  Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study.

Authors:  Jihye Park; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim; Dong Ho Lee
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.